About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

High-Dose Dexamethasone Combined with Orelabrutinib

[2] Dexamethasone,
Orelabrutinib (Orelabrutinib)

[4] Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Orelabrutinib (Orelabrutinib) 💬

Name	Other Names
Dexamethasone	Decadron Maxidex DEXTENZA HEMADY OZURDEX DEXAMETHASONE INTENSOL TAPERDEX 12-DAY TAPERDEX 6-DAY
Dexamethasone sodium phosphate	Dalalone Maxidex
Dexamethasone phosphate	Decadron-phosphate
Orelabrutinib	Orelabrutinib

[2] BTK,
NR3C1 💬

[8] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬

[1] 63 💬

2

[1] Orelabrutinib (Orelabrutinib)

[1] Orelabrutinib (Orelabrutinib) 💬

[1] BTK 💬

[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬

[5] 13, 49, 53, 61, 63 💬

3

Orelabrutinib (High Dose)

[1] Orelabrutinib (Orelabrutinib)

[1] Orelabrutinib (Orelabrutinib) 💬

[1] BTK 💬

[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬

[1] 49 💬

4

Orelabrutinib (Low Dose)

[1] Orelabrutinib (Orelabrutinib)

[1] Orelabrutinib (Orelabrutinib) 💬

[1] BTK 💬

[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬

[1] 49 💬

5

Orelabrutinib( higher dose)

[1] Orelabrutinib (Orelabrutinib)

[1] Orelabrutinib (Orelabrutinib) 💬

[1] BTK 💬

[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬

[1] 63 💬

6

Orelabrutinib( lower dose)

[1] Orelabrutinib (Orelabrutinib)

[1] Orelabrutinib (Orelabrutinib) 💬

[1] BTK 💬

[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬

[1] 63 💬

7

Orelabrutinib-100

[1] Orelabrutinib (Orelabrutinib)

[1] Orelabrutinib (Orelabrutinib) 💬

[1] BTK 💬

[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬

[1] 61 💬

8

Orelabrutinib-150

[1] Orelabrutinib (Orelabrutinib)

[1] Orelabrutinib (Orelabrutinib) 💬

[1] BTK 💬

[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬

[1] 61 💬

9

Orelabrutinib-50

[1] Orelabrutinib (Orelabrutinib)

[1] Orelabrutinib (Orelabrutinib) 💬

[1] BTK 💬

[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬

[1] 61 💬